A diagnostic procedure utilizing oral fluid to identify the presence of ten specific substances or classes of drugs is a common method for substance abuse detection. This testing modality offers a non-invasive approach to sample collection, potentially mitigating issues related to adulteration or privacy concerns often associated with urine-based analyses. The panel typically includes screening for substances such as amphetamines, opiates, cocaine, benzodiazepines, and tetrahydrocannabinol (THC), among others, depending on the specific requirements of the testing program.
The adoption of oral fluid drug screening has grown due to its relative ease of administration and observed detection window that aligns well with recent substance use. This type of analysis can be valuable in workplace settings, criminal justice systems, and substance abuse treatment programs. Historically, urine drug screens were the standard; however, advancements in laboratory technology and the demand for less intrusive methods have contributed to the increased prevalence of oral fluid testing.